HK.AI Capital Limited Overview
HK.AI Capital Limited is a small, Hong Kong-based, Chapter 21-listed investment company. Its history runs from the Oriental Patron-sponsored OP Financial platform through a Liu Zhiwei-era rebrand as Wealthking, and then a 2023–2026 pivot to an AI-themed identity. For almost two decades its signature asset was a 22.5% founding stake in CSOP Asset Management, one of Hong Kong's largest ETF issuers. In FY2026 it sold that stake to GoFintech Quantum Innovation Limited (HKEX: 0290) in exchange for GoFintech shares. As a result it reported a record HK$6.17 billion attributable profit, almost entirely non-cash. The company is now essentially a holding vehicle. Its value is dominated by a listed GoFintech position, with smaller unlisted holdings (iCarbonX, Jiedaibao), funds, debt and artwork alongside. GoFintech is also its largest shareholder (about 26%), so the two companies hold shares in each other. The stock trades at roughly 0.08–0.10× reported NAV, which reflects concentration, governance and liquidity discounts.
What the company does. HK.AI Capital is an investment holding company. Its objective, as described in HKEX filings, is medium- to long-term capital appreciation from a diversified portfolio of listed and unlisted enterprises across Hong Kong, Mainland China and the United States. It has no operating business in the conventional sense. Its "revenue" is investment income: interest, dividends, share of associates' results, and realised and unrealised gains as classified by data providers. It runs on a very small team of about 20–23 staff.
Company's own description (paraphrased). In the 31 December 2024 joint announcement, the company described itself as principally engaged in investment holding in Hong Kong, the PRC and the USA, investing in a diversified global portfolio of listed and private enterprises. Earlier interim reports (2022/23, 2023/24) describe it as a cross-border, cross-sector investment platform with investing, financing and industry-consolidation capabilities. Those reports frame the portfolio in three buckets:
-
core holdings, held long term;
-
asset management, held mid- to long-term;
-
trading and others, held short term.
The FY2026 annual results reframed the strategy around five pillars: unlisted equity, debt, funds, listed equity, and artwork investments.
Revenue model.
The product/service/subscription/licensing framework does not apply. The business is purely investment income, with 100% "gross margin" per S&P presentation because there is no cost of revenue.
Value chain position. The company is a principal investor (balance-sheet capital). It is not an asset manager earning fees on third-party capital. Its exposure to asset-management economics came indirectly through CSOP. Since the disposal, that exposure runs through GoFintech, which now accounts for CSOP as a 22.5% associate.
Customer types / end-markets. It has no customers in the conventional sense. Counterparties are investee companies, co-investors and fund sponsors. Sector exposure has historically included healthcare and life sciences (iCarbonX), fintech (Jiedaibao), financial platforms (CSOP), TMT, and, after the rebrand, AI-related themes.
Independent characterisation. Today the company is effectively a closed-end holding vehicle. Its NAV is dominated by one listed security (GoFintech, a connected party), plus illiquid unlisted stakes whose fair values rest on management and valuer assumptions. The "AI" branding is not yet backed by a disclosed, material AI portfolio. The FY2026 results mention AI as a strategic theme, but holdings-level disclosure is limited. Recurring income has fallen for two consecutive years: aggregated revenue went from HK$308m in FY2024 to HK$217m in FY2026. Operating cash flow has been negative in every one of the last five years.
Strategy
Stated strategy themes (FY2026 annual results, paraphrased).
-
An "optimised" five-pillar allocation: unlisted equity, debt, funds, listed equity, artwork.
-
A thematic tilt toward AI and technology, signalled by the 2023 and 2026 rebrands and the appointment of an AI scientist as chair.
-
Leveraging the GoFintech relationship for deal flow and financial-services synergies, as set out in the December 2024 disposal rationale (access to investment banking and asset management capabilities).
-
Improving liquidity by converting the illiquid CSOP stake into listed GoFintech shares. The December 2024 announcement explicitly described GoFintech shares as highly liquid and readily convertible to cash.
Initiatives in the last 24 months.
After the terminated rights issue. Management said it would revise the business plans that the proceeds were meant to fund.
Medium-term financial targets / guidance. None publicly disclosed. As a Chapter 21 investment company, HK.AI does not issue earnings guidance.
ESG / sustainability commitments. None specific beyond statutory HKEX ESG reporting. Not publicly disclosed in accessible sources.
Cost programmes. No formal programme was announced. The September 2025 office downsizing suggests cost control.
Products & Services
As an investment company, HK.AI Capital's "products" are its portfolio holdings. Below is every holding or pillar identifiable from public disclosures.
Pricing model. Not applicable. The company does not charge fees to third parties.
Product Portfolio
| Holding / Offering | Pillar | Description | Size / Stake | Status | Source |
|---|---|---|---|---|---|
GoFintech Quantum Innovation Limited (HKEX: 0290) | Listed equity | HK cross-border investment and financial services platform (brokerage, investment banking, asset management, money lending). Now holds 22.5% of CSOP | 1,405,063,292 shares received as consideration (about 15.85% of the enlarged GoFintech share capital at announcement). Implied fair value about HK$6.4bn at 31 Mar 2026 (derived: about HK$3.7bn at completion plus about HK$2.66bn unrealised gain) | Held; largest single asset | Joint announcement 31 Dec 2024; FY2026 results |
iCarbonX Group Limited | Unlisted equity | Shenzhen-founded AI-driven digital health and life-sciences company | 7,960,784 shares, about 7.73% (31 Mar 2024) | Held; fair value not disclosed in accessible sources | Supplemental announcement, Feb 2025 |
Jiedaibao Limited | Unlisted equity | Chinese fintech / P2P lending platform | 21,269,700 shares, about 2.49% (31 Mar 2024) | Held | Supplemental announcement, Feb 2025 |
CSOP Asset Management Limited | Formerly associate | HK ETF issuer co-founded in 2008 with China Southern AM. AUM about HK$134.2bn (30 Sep 2024); 2023 revenue HK$768.4m; profit after tax HK$279.2m | 22.5% (60,000,000 shares) | Disposed in FY2026 | Joint announcement 31 Dec 2024 |
Other listed equity and funds | Listed equity / funds | Secondary-market holdings | Not itemised | Ongoing | FY2026 results |
Debt investments / loans | Debt | Bonds, loan receivables | Not itemised | Ongoing | FY2026 results |
Artwork | Artwork | Art assets | — | New pillar from FY2026 | FY2026 results |
Legacy: Nobel Holdings Investments | Unlisted (historic) | Co-investment with CIC (2008) | — | Current status not disclosed | Interim Report 2015/16 |
Legacy: OP Investment Management, Treasure-related 25% stake, BITIC | Historic financial platforms | OP-era financial platform investments | — | Current status not disclosed | Interim Report 2013/14; Annual Report 2016/17 |
“—” = not publicly disclosed.
Financial Narrative
Primary source for FY2025–FY2026 headline profit and NAV: company annual results. Line items: S&P Global Market Intelligence via StockAnalysis.com (last updated Jul 2026). The FY2026 attributable profit per the company is HK$6,171,833,000. FY2025 is HK$64,158,000.
Income statement
Revenue CAGR FY2022–FY2026: about 22.9% a year, from HK$95.2m to HK$217.3m (calculated). The CAGR is flattered by a low FY2022 base. Revenue has declined for two consecutive years since the FY2024 peak.
Commentary.
FY2022–FY2023: Profit exceeded revenue because of fair-value gains booked below the revenue line, a pattern that recurs.
FY2024–FY2025: Profits of HK$53.7m and HK$64.2m are modest relative to about HK$10bn of equity. Return on equity was below 1%.
FY2026 inflection: Profit came almost entirely from two non-cash items:
-
a gain on disposal of the CSOP associate of about HK$3.57bn;
-
about HK$2.66bn of unrealised fair-value gains on listed investments, essentially GoFintech shares.
Disposal gain versus original estimate: In December 2024 the company estimated a gain of only about HK$958m, based on the HK$1.11bn valuation less the HK$151m carrying amount. The realised gain was about 3.7× that estimate. Accounting measured the consideration shares at their fair value on completion, after GoFintech's share price had risen sharply from the HK$0.79 issue price.
Underlying earnings: Excluding the two items, the remainder was a small net loss of roughly HK$58m (6,172 − 3,570 − 2,660; derived).
Balance sheet
Commentary.
Equity growth: Equity nearly doubled from FY2022 to FY2023, from HK$5.5bn to HK$10.0bn. Shares rose from 4.06bn to 10.52bn over the same period, so NAV per share fell from HK$1.36 to HK$0.95. Growth was achieved through heavy share issuance, not compounding.
Debt reduction: Short-term borrowings were cut from HK$1.85bn (FY2022) to HK$198m (FY2026). The company is now effectively ungeared, with total liabilities at 1.6% of assets.
Source of liquidity: "Liquidity" now depends on the realisable value of GoFintech shares. Free cash was only HK$117m at 31 Mar 2026.
Cash flow
Commentary.
-
Operating cash flow has been negative in all five years. The company has funded overheads and investments through equity raises and asset sales.
-
FY2023 gross equity raised is the sum of the Sep 2022 (HK$802.6m) and Mar 2023 (HK$346.9m) subscriptions.
-
FY2026 gross equity raised is the Nov 2025 subscription of HK$261.5m.
Ratios (calculated on year-end balances)
Commentary.
-
FY2026 ROE of 37% is a non-recurring artefact of the disposal and mark-to-market gains. On recurring earnings, ROE has been below 1% since FY2024.
-
EBITDA, ROIC, interest coverage and cash conversion cycle are not meaningful for a Chapter 21 investment company and are not disclosed.
NAV per share trajectory (company monthly NAV announcements)
Mar-2025 is the unaudited figure; the audited FY2025 NAV was HK$0.95. Mar-2026 is the audited figure.
Commentary.
-
NAV per share was stable at about HK$0.95 for two years.
-
It dipped to HK$0.899 in January 2026, after the dilutive November 2025 subscription at HK$0.23.
-
It then rose to HK$1.42 at year-end and HK$1.68 at end-April 2026, driven by GoFintech's share price.
-
It fell 32% to HK$1.136 by end-June 2026, after GoFintech shares corrected sharply.
-
NAV is now essentially a leveraged proxy for GoFintech's share price.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Pillar Details
| Pillar | Content |
|---|---|
Unlisted equity | iCarbonX Group Limited, Jiedaibao Limited, other private stakes |
Debt investments | Loans, bonds and other fixed-income instruments |
Fund investments | PE/VC and other fund interests |
Listed equity | GoFintech Quantum Innovation (consideration shares) and other listed securities |
Artwork investments | New pillar; scale not publicly disclosed |
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total revenue all categories (HKD Mn) | 308.33 | 273.07 | 217.29 |
Total revenue YoY growth (%) | 59.97 | -11.44 | -20.43 |
Operating income all categories (HKD Mn) | 244.49 | 232.32 | 189.47 |
Operating margin (%) | 79.30 | 85.08 | 87.20 |
Segment Assets & Liabilities and Revenue by Segment
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Trading asset securities, mainly listed equity (HKD Mn) | 2092 | 1,856 | 7,740 |
Short-term investments (HKD Mn) | 3,677 | 2,745 | 2,164 |
Long-term investments, unlisted, associates, funds (HKD Mn) | 4,872 | 5,006 | 4,779 |
Other long-term assets (HKD Mn) | 0 | 283.1 | 1,416 |
Cash and equivalents (HKD Mn) | 45.01 | 58.47 | 116.88 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 95.23 | 192.74 | 308.33 | 273.07 | 217.29 |
Gross profit (HKD Mn) | 95.23 | 192.74 | 308.33 | 273.07 | 217.29 |
Operating income (HKD Mn) | 88.32 | 128.32 | 244.49 | 232.32 | 189.47 |
Pre-tax income (HKD Mn, derived from pretax margin) | 217.16 | 149.53 | 54.60 | 72.12 | 6,178.81 |
Net income attributable (HKD Mn) | 221.27 | 146.38 | 53.65 | 64.16 | 6,171.83 |
EPS basic (HKD) | 0.06 | 0.02 | 0.01 | 0.01 | 0.56 |
EPS diluted (HKD) | — | — | — | — | 0.56 |
Dividends per share (HKD) | — | — | — | — | 0 |
Gross margin (%) | 100 | 100 | 100 | 100 | 100 |
Operating margin (%) | 92.74 | 66.58 | 79.30 | 85.08 | 87.20 |
Net margin (%) | 232.35 | 75.95 | 17.40 | 23.49 | 2,840.41 |
Revenue growth (%) | -15.28 | 102.39 | 59.97 | -11.44 | -20.43 |
Balance Sheet and Share Count (M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 7,441 | 11,366 | 11,422 | 10,668 | 16,774 |
Cash and equivalents (HKD Mn) | 86.40 | 108.36 | 45.01 | 58.47 | 116.88 |
Cash and short-term investments incl. trading securities (HKD Mn) | 1,918 | 5,334 | 5,814 | 4,660 | 10,021 |
Short-term debt (HKD Mn) | 1,845 | 1,280 | 1,417 | 643.26 | 198.23 |
Long-term debt incl. leases (HKD Mn) | 29 | 14 | 10 | 8.12 | 5.31 |
Total debt (HKD Mn) | 1,874 | 1,294 | 1,427 | 651.38 | 203.54 |
Net debt vs cash only (HKD Mn) | 1,787.60 | 1,185.64 | 1,381.99 | 592.91 | 86.66 |
Shareholders' equity (HKD Mn) | 5,528 | 10,011 | 9,913 | 9,948 | 16,509 |
Goodwill and intangibles (HKD Mn) | 0.78 | 0.78 | 0.07 | 0 | 0 |
Working capital (HKD Mn) | 362.53 | 4,280 | 5,032 | 4,651 | 10,311 |
Total liabilities (HKD Mn) | 1,913 | 1,355 | 1,510 | 720.78 | 265.83 |
Shares outstanding (M) | 4,061 | 10,520 | 10,520 | 10,520 | 11,657 |
NAV / book value per share (HKD) | 1.36 | 0.95 | 0.94 | 0.95 | 1.42 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (HKD Mn) | -28.46 | -96.25 | -47.01 | -21.55 | -34.34 |
Capital expenditure (HKD Mn) | -1.79 | -3.74 | -2.48 | -0.13 | -0.03 |
Free cash flow (HKD Mn) | -30.25 | -99.99 | -49.48 | -21.68 | -34.38 |
Dividends paid (HKD Mn) | — | — | — | — | 0 |
Equity raised, gross, approximate (HKD Mn) | — | 1,149.5 | — | — | 261.5 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on ending equity (%) | 4.00 | 1.46 | 0.54 | 0.64 | 37.39 |
ROA on ending assets (%) | 2.97 | 1.29 | 0.47 | 0.60 | 36.79 |
Current ratio (x) | 1.19 | 4.18 | 4.35 | 7.48 | 40.14 |
Debt to equity (x) | 0.339 | 0.129 | 0.144 | 0.065 | 0.012 |
Asset turnover (x) | 0.013 | 0.017 | 0.027 | 0.026 | 0.013 |
Liabilities to assets (%) | 25.71 | 11.92 | 13.22 | 6.76 | 1.58 |
Per-Share Data
| Metric | Jan-2024 | May-2024 | Sep-2024 | Dec-2024 | Feb-2025 | Mar-2025 | Jul-2025 | Aug-2025 | Jan-2026 | Mar-2026 | Apr-2026 | Jun-2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NAV per share (HKD) | 0.952 | 0.959 | 0.965 | 0.945 | 0.950 | 0.957 | 0.962 | 0.966 | 0.899 | 1.420 | 1.680 | 1.136 |
Revenue by Region
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Hong Kong revenue (HKD Mn) | 30.91 | 137.56 | 232.97 | 196.36 | 159.98 |
Mainland China revenue (HKD Mn) | 42.02 | 51.55 | 70.73 | 71.61 | 51.74 |
United States revenue (HKD Mn) | 21.00 | 3.64 | 4.63 | 5.09 | 5.57 |
Total geographic revenue (HKD Mn) | 93.93 | 192.74 | 308.33 | 273.07 | 217.29 |
Region Margins & Growth (%) and Revenue by Region (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Hong Kong growth (%) | 69.36 | -15.71 | -18.53 |
Mainland China growth (%) | 37.21 | 1.24 | -27.75 |
United States growth (%) | 27.20 | 9.94 | 9.43 |
Hong Kong share of total (%) | 75.56 | 71.91 | 73.63 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Last price (30 Sep 2026) | HK$0.109 | StockAnalysis |
52-week range (as of Aug 2026) | HK$0.087 – HK$0.280 | StockAnalysis |
1-year performance (to 24 Jul 2026) | -1.05% | MarketInOut |
6-month performance (to 24 Jul 2026) | -51.79% | MarketInOut |
2-month performance (to 24 Jul 2026) | -56.48% | MarketInOut |
Beta | 1.22 | StockAnalysis |
Share Price
| Metric | Sep-2022 | Mar-2023 | Nov-2025 | Jun-2026 | Sep-2026 |
|---|---|---|---|---|---|
Issue price / reference price (HKD) | 0.50 | 0.39 | 0.23 | 0.11 | 0.109 |
Valuation Multiples
| Multiple | HK.AI | Basis |
|---|---|---|
P/E (trailing) | About 0.19× | S&P; distorted by non-recurring FY2026 gains |
P/B (vs Mar 2026 NAV of HK$1.42) | About 0.077× | Calculated |
P/NAV (vs Jun 2026 NAV of HK$1.136) | About 0.096× | Calculated |
EV/Sales | About 6.25× | Calculated: EV ≈ HK$1,271m market cap + HK$204m debt − HK$117m cash ≈ HK$1,358m, divided by HK$217m revenue |
P/S | About 5.79× | S&P |
Analyst Conclusions
Management guidance. None quantitative. Management intends to revise its business plans after the rights-issue termination. The strategy remains the five-pillar allocation with an AI tilt.
Consensus expectations. None available.
Bull case
-
Deep discount to NAV. At HK$0.109, the market values HK.AI at under 10% of its June 2026 unaudited NAV of HK$1.136. Even a 50% haircut on GoFintech and the unlisted stakes leaves substantial implied upside.
-
Debt-free balance sheet with a liquid, unrestricted core asset. Total debt is HK$204m against HK$16.5bn of equity. Selling part of the GoFintech position could fund buybacks or special dividends, now technically supported by HK$6.2bn of retained earnings.
-
Indirect CSOP franchise. Through GoFintech, HK.AI retains economic exposure to a market-leading ETF manager. CSOP grew profit after tax 45% in 2023 and manages about HK$134bn of AUM.
Bear case
-
NAV is fragile and circular. About 39% of NAV is one connected stock that owns 26% of HK.AI. GoFintech's weaker FY2026 results and sharp price falls have already cut NAV by about a third from its April peak.
-
Persistent value leakage. Negative OCF in each of five years and four dilutive raises at successively lower prices suggest the NAV discount reflects real expectations that minorities will not capture NAV.
-
No recurring earnings engine. With CSOP gone and no disclosed income-producing AI portfolio, recurring revenue may decline further. A failed rights issue limits fresh capital.
Key catalysts and monitorables (next 12 months)
| Catalyst | Timing | What to watch |
|---|---|---|
| Interim results (6 months to 30 Sep 2026) | About late Nov 2026 | GoFintech mark-to-market; recurring income without CSOP; cash position |
| Monthly NAV announcements | Mid-month | Direction of NAV per share vs HK$1.136 (Jun 2026) |
| Revised business plan after the rights issue | Unspecified | Funding source; whether GoFintech shares are monetised |
| Capital return | Any time | Buyback or dividend announcements given the NAV discount |
| GoFintech corporate actions | Ongoing | Results, fundraising, deal terminations, share-price trend |
| Board / executive changes | Ongoing | INED independence; CEO clarity; role of Mr. Tsang |
| Unlisted portfolio events | Ongoing | iCarbonX or Jiedaibao financing, IPO or write-downs |
Analyst verdict
HK.AI Capital is a case study in the gap between accounting value and shareholder value. On paper, FY2026 was transformational. A stake bought for about HK$60 million in 2008 produced about HK$3.57 billion of disposal gain, NAV per share rose roughly 50% to HK$1.42, and the balance sheet ended the year virtually debt-free. In substance, the company swapped a cash-generative, minority stake in a best-in-class ETF manager for a large block of shares in its own largest shareholder. That block has proven highly volatile, and the transaction deepened a circular ownership structure.
The market's verdict is unambiguous. The shares trade at under one-tenth of reported NAV, and a HK$641 million rights issue priced at HK$0.11 was withdrawn within a month because the stock fell through the issue price. Operating cash flow has been negative for five straight years. Equity has been raised repeatedly at falling prices, and no dividend was declared from a HK$6.2 billion profit. These facts suggest investors are discounting both the reliability of the reported NAV and the probability that minorities will ever capture it.
For the investment case to improve, management needs to show three things. First, it must convert part of the GoFintech position into cash at reasonable prices. Second, it must return capital, through buybacks or distributions, to narrow the discount. Third, it must build a transparent, income-producing portfolio that justifies the AI branding. The appointment of an executive director with private equity and M&A experience is a modest positive, but the board's growing overlap with GoFintech raises the bar for independent oversight.
Until such evidence appears, HK.AI is best characterised as a high-risk, deep-value special situation. Its outcome depends heavily on GoFintech's share price and on governance decisions that sit largely outside minority shareholders' control. Monitoring the November 2026 interim results and the monthly NAV prints is essential.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed / Tenure | Background | Source |
|---|---|---|---|---|
Prof. Lin Jing | Chairlady, non-executive director (designation per announcement) | 29 Jun 2026 | AI strategy expert; chief scientist of GoFintech Quantum Innovation Limited | FY2026 results announcement |
Mr. Tsang Sze Wai Claudius | Executive director | 28 Aug 2026 | Aged 49. Over 20 years in capital markets, private equity, M&A and SPACs. MBA, University of Chicago (Hong Kong), 1998. Director's fee HK$720,000 a year | Appointment announcement, 28 Aug 2026 |
Dr. Fu Weigang | Non-executive director | On board since at least Feb 2024 | Not publicly disclosed in accessible sources | NAV announcements |
Dr. Wang Shibin | Non-executive director | Since at least Feb 2024 | — | NAV announcements |
Ms. Sun Qing | Non-executive director | Since at least Dec 2024 | Also executive director of GoFintech (per GoFintech board list, Dec 2024) | Joint announcement, 31 Dec 2024 |
Mr. Yan Xiaotian | Independent non-executive director | Since at least Feb 2024 | — | NAV announcements |
Mr. Zhao Kai | Independent non-executive director | Since at least Feb 2024 | — | NAV announcements |
Mr. He Hongchun | Independent non-executive director | Appointed between Jun 2025 and Feb 2026 (replaced Mr. Yang Songbin) | — | NAV announcement, Feb 2026 |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
| 2019 | Dr. Liu Zhiwei became chairman | Liu-era rebrand to Wealthking followed |
Before Feb 2024 | Dr. | — |
Mid-2024 | Mr. Chen Yuming (INED) left; Mr. Yang Songbin joined | Board lists of Jun 2024 vs Oct 2024 NAV announcements |
9 Oct 2024 | Dr. Liu Zhiwei resigned as executive director | Ahead of the connected CSOP transaction |
By Dec 2024 | Ms. Sun Qing (GoFintech executive director) joined as NED | Deepened GoFintech linkage |
Jun 2025 – Feb 2026 | Mr. Yang Songbin replaced by Mr. He Hongchun (INED) | — |
29 Jun 2026 | Dr. Wang Qin resigned as chairman and NED; Prof. Lin Jing (GoFintech chief scientist) became chairlady | Further GoFintech integration |
28 Aug 2026 | Mr. Tsang Sze Wai Claudius appointed executive director | First executive director since Liu's departure. Board had operated with no executive directors from Oct 2024 |
Major Shareholders
| Holder | Shares | Stake | As of | Source |
|---|---|---|---|---|
GoFintech Quantum Innovation Limited (0290), indirect | 3,064,454,515 | 26.29% | 20 Nov 2025 | etnet (SFO disclosure) |
Ming Yang Capital Limited | 1,048,011,000 | 8.99% | 20 Nov 2025 | etnet |
Dr. Liu Zhiwei | — | About 0.22% | 31 Dec 2024 | Joint announcement |
Seven subscribers in the Nov 2025 placing | 1,136,955,997 combined | About 9.75% combined | 20 Nov 2025 | Subscription announcement |
Public / other | Remainder | About 55% | — | Derived |
“—” = not publicly disclosed.
Competitive Landscape
Key Competitors
| # | Peer | Ticker | Category | Relative positioning vs HK.AI |
|---|---|---|---|---|
| 1 | GoFintech Quantum Innovation Ltd | 0290.HK | Listed cross-border investment and financial services platform | Largest shareholder and largest investee. H1 FY2026 revenue about HK$1bn (supply-chain brokerage; thin margins). Reported a wider full-year FY2026 loss |
| 2 | China Merchants China Direct Investments | 0133.HK | Chapter 21 investment company (China direct investment) | Larger, longer-established, state-backed sponsor |
| 3 | China Innovation Investment Ltd | 1217.HK | HK-listed investment company | — |
| 4 | Capital VC Ltd | 2324.HK | HK-listed investment company | — |
| 5 | Value Partners Group | 0806.HK | Listed asset manager | Used as a comparable in the CSOP valuation (EV/EBITDA 28.88×, P/E 63.77× at Sep 2024) |
| 6 | Yunfeng Financial Group | 0376.HK | HK-listed financial / investment platform | — |
| 7 | CSOP Asset Management (unlisted) | — | ETF issuer | Former associate; now held by GoFintech |
| 8 | Oriental Patron Financial Group (private) | — | Former sponsor; cross-border financial services | Historic affiliate |
| 9 | Nippon Life India AM, UTI AMC, Platinum AM, SPARX, Azimut, MFC AM, Australian Ethical, Ashmore Indonesia | Various | Asian/global asset managers | Comparables used in the CSOP valuation |
| 10 | Global listed private-equity investors (e.g. 3i Group) | III.L | Listed PE investor | Aspirational structural comparison only |
Peer Comparison FY2026
| Metric | HK.AI (FY2026) | GoFintech (H1 FY2026) | Value Partners (Sep 2024 multiples) |
|---|---|---|---|
Revenue (HKD Mn) | 217.29 | About 1000 (6 months) | — |
Revenue growth (%) | -20.4 | About +4,500 YoY | — |
Net margin (%) | 2840 (non-recurring) | About 20 (H1 guidance HK$200–210m profit) | — |
R&D intensity (%) | 0 | — | — |
P/E (x) | About 0.19 | — | 63.77 |
“—” = not publicly disclosed.



